Peptide Therapeutics Market Report - Pfizer Inc., Eli Lilly and Company, Sanofi S.A, Glaxo - Benzinga
| LLY Stock | MXN 16,063 5.95 0.04% |
Slightly above 61% of Eli Lilly's investor base is looking to short. The analysis of current outlook of investing in Eli Lilly and suggests that many traders are alarmed regarding Eli Lilly's prospects. Eli Lilly's investing sentiment can be driven by a variety of factors including economic data, Eli Lilly's earnings reports, geopolitical events, and overall market trends.
Eli |
Peptide Therapeutics Market Report - Pfizer Inc., Eli Lilly and Company, Sanofi S.A, Glaxo Benzinga
Read at news.google.com
 |
Eli Lilly Fundamental Analysis
We analyze Eli Lilly's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Eli Lilly using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Eli Lilly based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Last Dividend Paid
Last Dividend Paid Comparative Analysis
Eli Lilly is currently under evaluation in last dividend paid category among its peers. Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
Eli Lilly Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Eli Lilly stock to make a market-neutral strategy. Peer analysis of Eli Lilly could also be used in its relative valuation, which is a method of valuing Eli Lilly by comparing valuation metrics with similar companies.
Peers
Eli Lilly Related Equities
| CVS | CVS Health | 0.46 | ||||
| SPORTS | Grupo Sports | 0.31 | ||||
| HOTEL | Grupo Hotelero | 0.26 | ||||
| MLM | Martin Marietta | 0.00 | ||||
| GNW | Genworth Financial | 0.00 | ||||
| LUV | Southwest Airlines | 0.75 | ||||
| AMP | Ameriprise Financial | 1.31 |
Additional Tools for Eli Stock Analysis
When running Eli Lilly's price analysis, check to measure Eli Lilly's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eli Lilly is operating at the current time. Most of Eli Lilly's value examination focuses on studying past and present price action to predict the probability of Eli Lilly's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eli Lilly's price. Additionally, you may evaluate how the addition of Eli Lilly to your portfolios can decrease your overall portfolio volatility.